Search details
1.
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
Clin Infect Dis
; 78(3): 756-764, 2024 03 20.
Article
in English
| MEDLINE | ID: mdl-38340060
2.
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 68(1): e0079423, 2024 Jan 10.
Article
in English
| MEDLINE | ID: mdl-38112526
3.
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 67(12): e0061123, 2023 12 14.
Article
in English
| MEDLINE | ID: mdl-37971239
4.
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
Antimicrob Agents Chemother
; 67(7): e0144822, 2023 07 18.
Article
in English
| MEDLINE | ID: mdl-37358463
5.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Article
in English
| MEDLINE | ID: mdl-36328357
6.
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children.
J Antimicrob Chemother
; 78(10): 2481-2488, 2023 10 03.
Article
in English
| MEDLINE | ID: mdl-37596982
7.
Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers.
Br J Clin Pharmacol
; 2023 Jan 24.
Article
in English
| MEDLINE | ID: mdl-36692865
8.
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children.
Clin Infect Dis
; 74(8): 1372-1381, 2022 04 28.
Article
in English
| MEDLINE | ID: mdl-34286843
9.
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis.
Clin Infect Dis
; 75(10): 1772-1780, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-35377434
10.
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
Antimicrob Agents Chemother
; 66(5): e0214421, 2022 05 17.
Article
in English
| MEDLINE | ID: mdl-35404075
11.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(6): e0226421, 2022 06 21.
Article
in English
| MEDLINE | ID: mdl-35506699
12.
Drug concentration at the site of disease in children with pulmonary tuberculosis.
J Antimicrob Chemother
; 77(6): 1710-1719, 2022 05 29.
Article
in English
| MEDLINE | ID: mdl-35468189
13.
Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies.
Clin Infect Dis
; 72(6): 1067-1073, 2021 03 15.
Article
in English
| MEDLINE | ID: mdl-32594142
14.
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
J Antimicrob Chemother
; 76(12): 3237-3246, 2021 11 12.
Article
in English
| MEDLINE | ID: mdl-34529779
15.
Caregiver-child separation during tuberculosis hospitalisation: a qualitative study in South Africa.
S Afr J Psychol
; 51(3): 409-421, 2021 Sep 01.
Article
in English
| MEDLINE | ID: mdl-34456393
16.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Clin Infect Dis
; 70(3): 436-445, 2020 01 16.
Article
in English
| MEDLINE | ID: mdl-30919881
17.
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
Clin Infect Dis
; 70(3): 425-435, 2020 01 16.
Article
in English
| MEDLINE | ID: mdl-30942853
18.
Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Article
in English
| MEDLINE | ID: mdl-31871093
19.
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
Emerg Infect Dis
; 25(3): 441-450, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30789141
20.
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
PLoS Med
; 16(8): e1002882, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31415563